Gastric and Pancreatic Lesions in Rats Treated with a Pan-CDK Inhibitor
Open Access
- 1 December 2005
- journal article
- research article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 33 (7), 784-791
- https://doi.org/10.1080/01926230500455862
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cleavage of cten by caspase-3 during apoptosisOncogene, 2005
- CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repairNature, 2005
- Targeted cancer therapyNature, 2004
- Cell differentiation, caspase inhibition, and macromolecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugsExperimental Cell Research, 2004
- A Structural Analysis of the Qualitative Networks Regulating the Cell Cycle and ApoptosisCell Cycle, 2003
- Gastric stem cells: an update.The Keio Journal of Medicine, 2003
- CYCLINS AND CELL CYCLE CHECKPOINTSAnnual Review of Pharmacology and Toxicology, 1999
- Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivoCell, 1995
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- G 1 Events and Regulation of Cell ProliferationScience, 1989